Corporate Banner
Satellite Banner
Chemical Process Scale Up
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New for World Vaccine Congress TAP’s Cellmate Mk9 Automated Cell Culture System

Published: Thursday, October 10, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
Designed for safe, high-throughput viral vaccine production.

TAP Biosystems has announced that it will introduce its new Cellmate™ Mk9 automated cell culture system at the World Vaccine Congress in Lille, France.

The new system is designed for safe, high throughput production of adherent cell-based vaccines in a GMP environment.

Cellmate Mk 9 is an evolution of TAP’s well-established Cellmate technology which automates the manufacturing processes associated with production of vaccines using adherent cell-based methods in roller bottles and T-flasks within a Class 100 laminar airflow cabinet.

The latest Cellmate system can be UL certified and include in-line particle counter that can be used to monitor non-viable particle loading in the processing area.

The in-line particle monitoring helps address increasing demands from regulators for assurance about the environmental quality used in manufacturing processes.

Cellmate Mk9 supports the OPC interoperability standard for industrial automation allowing users remote access to process information.

The Cellmate software retains 21 CFR Part 11 compliance and TAP provides full support for IQ and OQ, which makes implementing Cellmate into GMP vaccine production facilities a straightforward task.

Dr Dave Thomas, Product Manager at TAP Biosystems commented: “The Cellmate system is widely accepted by regulatory authorities for use in the manufacture of vaccines that have proved difficult to adapt for growth in bioreactors. Worldwide, many of our Cellmate systems have been installed for the GMP production of influenza, rabies and chicken pox vaccines using Vero, MDCK and other cell lines so Cellmate is a proven technology with a good track record in vaccine manufacturing.”

Thomas added: “To ensure our technology continues to provide a low-risk manufacturing strategy, compliant with new regulatory, validation and safety demands, we are introducing our new Cellmate Mk 9 at the World Vaccine Congress. We look forward to meeting scientists at the show and to discussing how the progression of Cellmate’s capabilities can offer them an excellent, safe scale-up option for vaccine production.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
Scientific News
Solvent-free, Catalyst-free Peracetylation of Natural Products
In this study, a tunable microwave-assisted method for the solvent-free and catalyst-free peracetylation of natural products was developed.
Sonochemical Reactors
A critical analysis of the underlying mechanisms for intensification, available reactor configurations and overview of the different applications exploited successfully are presented.
Economical and Scalable Synthesis of 6-amino-2-cyanobenzothiazole
An economical and scalable synthesis of ACBT is presented, along with advantages for scale-up over previously reported routes.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Cutting the Cost of Drug-Building Chemicals
EPFL scientists have developed a method to produce aryl-containing amines in a cheap and easily scalable way.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!